2026 SNO Clinical Trial Design and Protocol Development Workshop
The Society for Neuro-Oncology is pleased to announce the 8th Annual Clinical Trial Design and Protocol Development Workshop. This year’s workshop will be held in person on Wednesday, November 11, in Philadelphia, PA, just prior to the SNO Annual Meeting and Education Day.
Educational Goals
Upon completion of this course, participants in Parts 1 and 2 will have an improved understanding of the practical aspects of CNS trials, including:
- Fundamentals of good trial design and protocol development,
- Scientific, statistical, regulatory, logistical and ethical aspects of CNS trials,
- Integration of correlative studies in CNS trials,
- Mitigating challenges to accrual and overcoming accrual barriers, and
- Anticipating the future direction of CNS trials
Participants in Clinical Research/Allied Health will have an improved understanding of some basic aspects of neuro-oncology and an overview of the clinical trial enterprise including:
- Classification of brain tumors
- Common symptoms and medications used in brain tumor patients
- Basic clinical trial design and endpoints
- Elements to launch a trial
- Post activation clinical trial activities
* Please see the Instructions & Lesson Files section on the top header bar for the current program.
Planning Committee
Maryam Fouladi, Nationwide Children's Hospital (Co-chair)
Susan Geyer, Mayo Clinic
Mustafa Khasraw, Duke University
Karishma Kumar, University of California, San Francisco (Co-chair)
Ian Parney, Mayo Clinic (Co-chair)
Jane Rabbitt, University of California, San Francisco (Co-chair)
Patrick Wen, Dana-Farber Cancer Institute
Presenting Faculty
Christina Amidei, Northwestern University
Terri Armstrong, National Cancer Institute
Joshua Budhu, Memorial Sloan Kettering Cancer Center
Susan Chang, University of California, San Francisco
Ugonma Chukwueke, Dana-Farber Cancer Institute
Jennifer Clarke, University of California, San Francisco
Tim Cloughesy, University of California, Los Angeles
Amylou Dueck, Mayo Clinic
Erin Dunbar, Piedmont Brain Tumor Center
Maryam Fouladi, Nationwide Children’s Hospital
Evanthia Galanis, Mayo Clinic
Susan Geyer, Mayo Clinic
Mark Gilbert, National Institutes of Health
Stuart Grossman, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Kathy Hunter, RN
Mustafa Khasraw, Duke University
Minesh Mehta, Miami Cancer Institute
Annette Molinaro, University of California, San Francisco
Ian Parney, Mayo Clinic
Eudocia Quant Lee, Dana-Farber Cancer Institute
Steven Piantadosi, Brigham and Women’s Hospital
Vinay Puduvalli, University of Texas MD Anderson Cancer Center
Rif Rahman, Dana-Farber Cancer Institute
David Reardon, Dana-Farber Cancer Institute
Erik Sulman, NYU Langone Medical Center
Martin van den Bent, Erasmus MC Cancer Center
Patrick Wen, Dana-Farber Cancer Institute
Nicole Wilmarth, American Brain Tumor Association